Q98440522

Summary

Q98440522 is an interpellation^[1].

Key Facts

• Q98440522 authored Morgan Johansson^[2].
• Q98440522's instance of is recorded as interpellation^[3].
• Q98440522's part of the series is recorded as interpellations of the 2009/10 legislative session of the Riksdag^[4].
• Q98440522's language of work or name is recorded as Swedish^[5].
• Q98440522's publication date is recorded as +2010-03-05T00:00:00Z^[6].
• Q98440522's significant event is recorded as debate^[7].
• Q98440522's main subject is recorded as medication^[8].
• Q98440522's work available at URL is recorded as http://data.riksdagen.se/dokument/GX10281^[9].
• Q98440522's work available at URL is recorded as http://data.riksdagen.se/dokumentstatus/GX10281^[10].
• Q98440522's applies to jurisdiction is recorded as Sweden^[11].
• Q98440522's legal citation of this text is recorded as ip. 2009/10:281^[12].
• Q98440522's title is recorded as Läkemedelsindustrins framtid och nedläggningen av Astra Zeneca i Lund^[13].
• Q98440522's addressee is recorded as Maud Olofsson^[14].
• Q98440522's maintained by WikiProject is recorded as Project Riksdagen's documents^[15].
• Q98440522's copyright status is recorded as public domain^[16].
• Q98440522's Swedish Riksdag document ID is recorded as GX10281^[17].

Body

Works and Contributions

Q98440522 authored Morgan Johansson^[2].